Search Results 51-60 of 17893 for lupus

  1. Belimumab (intravenous route, subcutaneous route) - Mayo Clinic

    Belimumab injection is used to treat active, autoantibody-positive, systemic lupus erythematosus (SLE) and active lupus nephritis in patients who are also ...

  2. Voclosporin (oral route) - Mayo Clinic

    Voclosporin is used to treat active lupus nephritis. It is a calcineurin inhibitor that changes the immune system to help control lupus symptoms. This ...

  3. Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis - Mayo Clinic

    Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis ... Lupus Nephritis (LN).

  4. A 2-stage, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/​or Subacute Cutaneous Lupus Erythematosus (LAVENDER) - Mayo Clinic

    This study aims to evaluate the efficacy and safety of subcutaneous (SC) anifrolumab versus placebo in adult participants with cutaneous lupus erythematosus ( ...

  5. Dr. Thomas Osborn Archives - Mayo Clinic News Network

    ... Lupus is a chronic inflammatory disease that occurs when your body's immune ... lupus can affect many different body systems — including your joints ...

  6. RESET-SLE: A Phase 1/​2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus - Mayo Clinic

    The purpose of this study is to evaluate the safety and tolerability of CABA-201 in subjects with active Systemic Lupus Erythematosus. Participation eligibility.

  7. Vasculitis - Symptoms and causes - Mayo Clinic

    Blood cancers. Immune system diseases, such as rheumatoid arthritis, lupus and scleroderma. Reactions to certain medicines. Risk factors. Vasculitis can happen ...

  8. Publications - Ali A. Duarte Garcia, M.D. - Mayo Clinic

    ... Lupus Erythematosus: A Study From Lupus ... Fragility of randomised controlled trials for systemic lupus erythematosus and lupus nephritis therapies.

  9. Anifrolumab-fnia (intravenous route) - Mayo Clinic

    Anifrolumab-fnia injection is used to treat moderate to severe systemic lupus erythematosus (SLE) in patients who are also receiving other lupus treatments.

  10. Polymorphous light eruption - Diagnosis & treatment - Mayo Clinic

    Lupus rash. Lupus is an inflammatory disorder that affects a number of body systems. One symptom is the appearance of a bumpy rash on skin exposed to ...